Skip to main content
Interview with the Innovators
Lung Cancer, FDA Updates
April 16, 2019 – FDA Approvals, News & Updates
Yvette Florio Lane
Read More
Lung Cancer, FDA Updates
FDA Approves Tecentriq plus Chemotherapy for First-Line Treatment of Extensive-Stage Small-Cell Lung Cancer
Yvette Florio Lane
Read More
Lung Cancer
Brigatinib, Next-Generation ALK Inhibitor, Improves Survival versus Crizotinib in Patients with NSCLC and ALK Mutation
Phoebe Starr
Read More
FDA Updates, Lung Cancer
Alunbrig (Brigatinib) Approved for Metastatic NSCLC with ALK Mutation
Lisa A. Raedler, PhD, RPh, Medical Writer
Read More
Lung Cancer
Adjusted Dosing and Schedule of Pemetrexed in Impaired Renal Function
Zahava Ohana, PharmD, Amanda Brahim, PharmD, BCPS, Mohammed Ibrahim, RPh, BCOP, BCPS, BCACP
Read More
Online First
Lung Cancer
PROCLAIM Study Fails to Identify Best Regimen for Locally Advanced Lung Cancer
Alice Goodman
Read More
Page 12 of 12
Results 111 - 116 of 116